메뉴 건너뛰기




Volumn 7, Issue 1, 2007, Pages 49-55

New horizons in diabetes therapy

Author keywords

Appetite; DPP IV inhibitor; Food intake; Gastrointestinal tract; Glucagon like peptide 1 (GLP 1)

Indexed keywords

6 [[2 [[2 (2 CYANO 1 PYRROLIDINYL) 2 OXOETHYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; ALBUGON; ALBUMIN; CJC 1131; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN; ISOLEUCINE THIAZOLIDIDE; LIRAGLUTIDE; METFORMIN; PLACEBO; SITAGLIPTIN; SULFONYLUREA; VILDAGLIPTIN;

EID: 34247154285     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152207779802545     Document Type: Review
Times cited : (3)

References (94)
  • 39
    • 12144260853 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 can directly protect the heart against ischemia/ reperfusion injury
    • Bose, A.K.; Mocanu, M.M.; Carr, R.D.; Brand, C.L.; Yellon, D.M. Glucagon-like peptide 1 can directly protect the heart against ischemia/ reperfusion injury. Diabetes 2005, 54, 146-151.
    • (2005) Diabetes , vol.54 , pp. 146-151
    • Bose, A.K.1    Mocanu, M.M.2    Carr, R.D.3    Brand, C.L.4    Yellon, D.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.